Molbio Diagnostics Invests $30 Million in OptraSCAN to Revolutionize Digital Pathology

BioNTech Acquires Chinese Oncology Firm Biotheus for $950M

The Care and Protection of Children Trust

CPCT Launches Groundbreaking Initiative to Provide Lifelong Free Treatment for Children with Spinal Muscular Atrophy (SMA) in Karnataka

Early Comprehensive Genomic Profiling Improves Cancer Treatment Outcomes, Study Shows

EMA Reverses Decision, Recommends Limited Approval for Eisai and Biogen’s Alzheimer’s Drug Leqembi

Exact Sciences Unveils Advances in Multi-Cancer Early Detection with Cancerguard™ Test

MSD and LaNova Medicines Enter Exclusive Global License Agreement for Novel Cancer Therapy, LM-299

Promising CAR T Cell Therapies from BMS and Cabaletta Bio Show Potential for Durable Remission in Severe Lupus

FDA Grants Accelerated Approval to PTC Therapeutics' KEBILIDI™, the First Gene Therapy for AADC Deficiency in the U.S.

Association for Molecular Pathology Publishes Joint Consensus Report on SARS-CoV-2 Genomic Surveillance for Hospitals and Public Health Laboratories

Philips India Unveils Advanced Azurion Imaging System to Revolutionize Cardiac and Neurovascular Care

Tempus AI Study Highlights Benefits of Dual RNA and DNA Sequencing for Advanced Lung Cancer

Ontada and Datavant Partner to Expand Access to Real-World Oncology Data for Accelerated Cancer Innovation

Tempus AI and Flatiron Health Partner to Integrate Genomic Testing into OncoEMR for Enhanced Oncology Care

Flare Therapeutics and Roche Forge Strategic Partnership to Discover Precision Oncology Therapies Targeting Transcription Factors

Home
/
update
/
details

Quad Cancer Moonshot: A United Effort to Eliminate Cervical Cancer in the Indo-Pacific

NextEdge Admin

22 Sep 2024

2 min 34 sec

The Quad countries—United States, Australia, India, and Japan—are launching the Quad Cancer Moonshot to combat cervical cancer in the Indo-Pacific, marking a significant step toward addressing cancer in the region. This initiative aims to enhance cancer care by improving healthcare infrastructure, expanding research collaborations, and boosting cancer prevention, detection, treatment, and care.

Cervical cancer, largely preventable through HPV vaccination and early detection, remains a major health crisis in the region, being the third leading cause of cancer deaths among women. However, fewer than 10% of women in the Indo-Pacific have completed HPV vaccination or undergone recent screenings. The initiative focuses on closing these gaps by promoting HPV vaccination, improving access to screening, and expanding treatment in underserved areas.

India plays a critical role, committing $7.5 million worth of HPV sampling kits, detection tools, and vaccines, and providing technical support through its National Non-Communicable Disease (NCD) portal. India is also scaling up screening for oral, breast, and cervical cancers using the cost-effective Visual Inspection with Acetic Acid (VIA) method, making early detection accessible even in resource-limited areas. Additionally, India is expanding specialized cancer treatment centers and offering affordable cancer care through the Pradhan Mantri Jan Arogya Yojana (PMJAY) program.

Collaborating with global organizations like Gavi, WHO, and the International Atomic Energy Agency, Quad countries aim to lower the cost of cervical cancer diagnostics and improve access to quality care. This united effort will not only prevent cervical cancer but also lay the groundwork for addressing other cancers, potentially saving hundreds of thousands of lives in the decades ahead.